3-(p-Fluorobenzoyloxy)tropane

3-(p-Fluorobenzoyloxy)tropane

Systematic (IUPAC) name
(1R,5S)-(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)-4-fluorobenzoate
Clinical data
Legal status	DE: Anlage II (Prohibited)
Routes of administration	insufflated
Identifiers
CAS Number	172883-97-5 N
PubChem	CID: 5147770
ChemSpider	4321292 Y
Chemical data
Formula	C15H18FNO2
Molecular mass	263.307 g/mol
SMILES CN1C2CC(OC(C3=CC=C(F)C=C3)=O)CC1CC2
InChI InChI=1S/C15H18FNO2/c1-17-12-6-7-13(17)9-14(8-12)19-15(18)10-2-4-11(16)5-3-10/h2-5,12-14H,6-9H2,1H3 Y Key:YXDFSLSXLYAAPF-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

3β-(p-Fluorobenzoyloxy)tropane, (8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 4-fluorobenzoic acid ester, 4-fluorotropacocaine, 3-Pseudotropyl-4-fluorobenzoate, 3-pseudotropyl-4-fluorobenzoate, pFBT) is a tropane derivative drug which acts as a local anaesthetic, having around 30% the stimulant potency of cocaine but around the same potency as a local anaesthetic. It has been investigated as a potential radiolabelled agent for studying receptor binding, but was not adopted for this application. The main application for fluorotropacocaine however has been as a designer drug analogue of cocaine, first detected by the EMCDDA in 2008, and subsequently sold as an ingredient of various "bath salt" powder products, usually mixed in combination with other stimulant drugs such as caffeine, dimethocaine, desoxypipradrol or substituted cathinone derivatives.

See also

• 4'-Fluorococaine
• Tropacocaine